Epoetin alfa protocol and multidisciplinary blood-conservation program for critically ill patients

Area of Science:

• Critical Care Medicine
• Pharmacoeconomics
• Hematology

Background:

• Anemia is common in intensive care units (ICUs), often leading to red blood cell (RBC) transfusions.
• Epoetin alfa is used to treat anemia, but its efficacy and appropriate use in critical illness require optimization.
• Blood conservation programs aim to minimize unnecessary blood draws and transfusions.

Purpose of the Study:

• To implement and evaluate an evidence-based epoetin alfa protocol.
• To establish a multidisciplinary blood conservation program in medical and surgical ICUs.
• To assess the impact of these interventions on epoetin alfa use and RBC transfusion rates.

Main Methods:

• Collected baseline data on epoetin alfa use and RBC transfusions in MICU and SICU.
• Designed and implemented an evidence-based epoetin alfa protocol and a blood conservation program.
• Compared pre- and post-intervention data, including patient samples and all ICU patients during the post-intervention period.

Main Results:

• Statistically significant improvements in epoetin alfa dosing, monitoring, and adjunctive therapy use were observed.
• Pharmacist-led blood conservation strategies led to reductions in blood draws.
• Significant reductions in RBC units transfused per patient and per ICU day were achieved.

Conclusions:

• The epoetin alfa protocol and blood conservation program facilitated rational prescribing of epoetin alfa.
• These interventions successfully reduced RBC transfusion requirements per patient and per ICU day.
• The multidisciplinary approach enhanced blood management strategies in critical care settings.